1. Pathological response in children and adults with large unresected intermediate-grade or high-grade soft tissue sarcoma receiving preoperative chemoradiotherapy with or without pazopanib (ARST1321): a multicentre, randomised, open-label, phase 2 trial. Issue 8 (August 2020) Authors: Weiss, Aaron R; Chen, Yen-Lin; Scharschmidt, Thomas J; Chi, Yueh-Yun; Tian, Jing; Black, Jennifer O; Davis, Jessica L; Fanburg-Smith, Julie C; Zambrano, Eduardo; Anderson, James; Arens, Robin; Binitie, Odion; Choy, Edwin; Davis, Justin W; Hayes-Jordan, Andrea; Kao, Simon C; Kayton, Mark L; Kessel... Journal: Lancet oncology Issue: Volume 21:Issue 8(2020) Page Start: 1110 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Selective IL-23 Inhibition by Risankizumab Modulates the Molecular Profile in the Colon and Ileum of Patients With Active Crohn's Disease: Results From a Randomised Phase II Biopsy Sub-study. (19th July 2018) Authors: Visvanathan, Sudha; Baum, Patrick; Salas, Azucena; Vinisko, Richard; Schmid, Ramona; Grebe, Kristie M; Davis, Justin W; Wallace, Kori; Böcher, Wulf O; Padula, Steven J; Fine, Jay S; Panés, Julián Journal: Journal of Crohn's and colitis Issue: Volume 12:Number 10(2018:Oct.) Page Start: 1170 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗